Literature DB >> 19129652

Induction of differentiation in k562 cell line by nicotinic acid-related compounds.

Chieri Ida1, Shin Ogata, Katsuzumi Okumura, Hiroshi Taguchi.   

Abstract

Nicotinic acid and nicotinamide belong to the water-soluble vitamins, and they have many physiological and pharmacological functions in various organisms. In this study, we investigated the differentiation-inducing ability of nicotinic acid-related compounds in chronic myelogenous leukemia K562 cell line. Proliferation of K562 leukemia cells was inhibited by several nicotinic acid-related compounds. Hemoglobin content was increased by nicotinic acid and by isonicotinic acid. Isonicotinic acid increased gamma-globin mRNA expression as much as sodium butyrate did. The nuclei of nicotinic acid and of isonicotinic acid-treated cells decreased in size and the chromatin became more condensed. It was verified that nicotinic acid and isonicotinic acid induced erythroid differentiation in K562 cells. Expression of glycophorin A was increased by sodium butyrate. In contrast, it was decreased by nicotinic acid and by isonicotinic acid, suggesting that these compounds differentiate K562 to erythrocytes through different pathways than sodium butyrate does. Our data perhaps provide useful information as to the mechanisms of cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129652     DOI: 10.1271/bbb.80483

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

1.  C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.

Authors:  Eleonora Brognara; Ilaria Lampronti; Giulia Breveglieri; Alessandro Accetta; Roberto Corradini; Alex Manicardi; Monica Borgatti; Alessandro Canella; Chiara Multineddu; Rosangela Marchelli; Roberto Gambari
Journal:  Eur J Pharmacol       Date:  2011-09-21       Impact factor: 4.432

2.  Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells.

Authors:  Yuefeng Yang; Xiaoyun Liu; Fengjun Xiao; Shuya Xue; Qinqin Xu; Yue Yin; Huiyan Sun; Jie Xu; Hengxiang Wang; Qunwei Zhang; Hua Wang; Lisheng Wang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 3.  Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders.

Authors:  Ali Dehghani Fard; Seyed Ahmad Hosseini; Mohammad Shahjahani; Fatemeh Salari; Kaveh Jaseb
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

4.  mTORC1 activity is essential for erythropoiesis and B cell lineage commitment.

Authors:  Natasha Malik; Karen M Dunn; Jennifer Cassels; Jodie Hay; Christopher Estell; Owen J Sansom; Alison M Michie
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

5.  NAD Modulates DNA Methylation and Cell Differentiation.

Authors:  Simone Ummarino; Clinton Hausman; Giulia Gaggi; Lucrezia Rinaldi; Mahmoud A Bassal; Yanzhou Zhang; Andy Joe Seelam; Ikei S Kobayashi; Marta Borchiellini; Alexander K Ebralidze; Barbara Ghinassi; Bon Q Trinh; Susumu S Kobayashi; Annalisa Di Ruscio
Journal:  Cells       Date:  2021-11-02       Impact factor: 7.666

Review 6.  Methods to Produce Nicotinic Acid with Potential Industrial Applications.

Authors:  Dawid Lisicki; Kinga Nowak; Beata Orlińska
Journal:  Materials (Basel)       Date:  2022-01-20       Impact factor: 3.623

7.  Voltage-Gated K+ Channel, Kv3.3 Is Involved in Hemin-Induced K562 Differentiation.

Authors:  Min Seok Song; Seon Young Choi; Pan Dong Ryu; So Yeong Lee
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.